Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evogene Ltd (NYSE:EVGN)

5.95
Delayed Data
As of Feb 12
 -0.10 / -1.65%
Today’s Change
5.93
Today|||52-Week Range
10.54
-26.09%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close6.05
Today’s open6.03
Day’s range5.93 - 6.04
Volume4,893
Average volume (3 months)9,667
Market cap$151.4M
Dividend yield--
Data as of 4:01pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-28.89%
Earnings growth (this year)-25.86%
Earnings growth (next 5 years)--
Revenue growth (last year)-17.46%
P/E ratio--
Price/Sales16.06
Price/Book1.30

Competitors

 Today’s
change
Today’s
% change
CLSHCLS Holdings USA Inc+0.01+0.83%
IKNXIkonics Corp+0.01+0.09%
OCIPOCI Partners LP+0.06+0.91%
CCMPCabot Microelectroni...-0.17-0.48%
Data as of 4:02pm ET, 02/12/2016

Financials

Next reporting dateMarch 1, 2016
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$14.5M
Annual profit (last year)-$14.5M
Net profit margin-100.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Financial Officer
Sigal Fattal
Corporate headquarters
Rehovot, Tel Aviv

Forecasts

Partner Offers